PharmAust's wholly owned subsidiary, Epichem, is one of the first Australian companies to receive an international quality assurance accreditation coveted by manufacturers of pharmaceutical drugs. ISO17034:2016 covers the production of reference material used to check the quality of products or the calibration of instruments. Pharmaust is also rapidly progressing its promising Monepantel ant-cancer drug.
